


| Key | % Net Assets |
|---|---|
| 5.1% | |
| 4.9% | |
| 3.2% | |
| 2.7% | |
| 84.1% |
| Name | % Net Assets |
|---|---|
| Roche Holding AG | 5.1% |
| Novartis AG | 4.9% |
| Telefonica S.A. | 3.2% |
| Total S.A. | 2.7% |
| Zurich Financial Services | 2.5% |
| Koninklijke KPN N.V. | 2.3% |
| E.ON AG | 2.2% |
| Sanofi-Aventis S.A. | 2.0% |
| Nokia Corp. | 2.0% |
| Reed Elsevier N.V. | 1.7% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 24/01/2007 |
|---|---|
| Fund Manager | n/a |
| TER | 2.00 (31-Jul-2010) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research